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Abstract
The Evaluation of Daily Activity Questionnaire (EDAQ) is a detailed patient-reported outcome measure of activity ability. 
The objective of this research was to assess the linguistic and cross-cultural validity and psychometric properties of the 
EDAQ in rheumatoid arthritis for Dutch and German speakers. The EDAQ was translated into Dutch and German using 
standard methods. A total of 415 participants (Dutch n = 252; German n = 163) completed two questionnaires about four 
weeks apart. The first included the EDAQ, Health Assessment Questionnaire (HAQ) and 36-item Short-Form v2 (SF-36v2) 
and the second, the EDAQ only. We examined construct validity using Rasch analysis for the two components (Self-Care 
and Mobility) of the Dutch and German EDAQ. Language invariance was also tested from the English version. We examined 
internal consistency, concurrent and discriminant validity and test–retest reliability in the 14 EDAQ domains. The Self-Care 
and Mobility components satisfied Rasch model requirements for fit, unidimensionality and invariance by language. Inter-
nal consistency for all 14 domains was mostly good to excellent (Cronbach’s alpha ≥ 0.80). Concurrent validity was mostly 
strong: HAQ rs = 0.65–0.87; SF36v2 rs = − 0.61 to − 0.87. Test–retest reliability was excellent [ICC (2,1) = 0.77–0.97]. The 
EDAQ has good reliability and validity in both languages. The Dutch and German versions of the EDAQ can be used as a 
measure of daily activity in practice and research in the Netherlands and German- speaking countries.
Keywords Rehabilitation · Outcome assessment · Activities of daily living · Rheumatoid arthritis · Rasch analysis · 
Occupational therapy
Introduction
Patient-Reported Outcome Measures (PROMs) are used in 
clinical practice and research to identify patients with rheu-
matic and musculoskeletal conditions’ (RMDs) functional 
problems and evaluate the effectiveness of rehabilitation for 
these. Most commonly, daily activities in the International 
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Classification of Functioning, Disability and Health (ICF) 
domains of communication, mobility, self-care and domes-
tic life are assessed [1]. There is no single PROM of daily 
activities widely used by rheumatology health profession-
als (RHPs) in Europe. Those commonly used in rheumatoid 
arthritis (RA) research, for example, include between 10 and 
21 activities [2–7]. In practice, RHPs often prefer non-vali-
dated daily activity checklists, including up to 55 activities 
[8], because they provide detailed information for individual 
treatment planning. However, such checklists lack reliability 
and validity to evaluate rehabilitation.
Consequently, a reliable, valid comprehensive daily activ-
ity PROM, including activities identified as problematic by 
people with RMDs, would be valuable: for treatment plan-
ning and evaluation; and in audit and research. The Evalua-
tion of Daily Activity Questionnaire (EDAQ) was developed 
in Sweden, with women with RA, to meet these needs [9]. It 
takes patients 30 min to complete at home, allowing reflec-
tion on activity abilities. During rehabilitation, RHPs can 
quickly focus on identified problems, allowing more time 
for solutions.
The EDAQ has been extensively updated, culturally and 
linguistically validated and psychometrically tested in Eng-
lish. British men and women with RMDs identified new 
items and domains to include. It has been tested in eight 
RMDs: RA, ankylosing spondylitis (AS), osteoarthritis 
(OA), systemic lupus erythematosus, systemic sclerosis, 
chronic pain, chronic upper limb disorders and Primary 
Sjögren’s syndrome [8, 10–12]. Construct representation 
identified activities in the EDAQ rated as more difficult in 
RA require: greater overall physical demand, bilateral and 
fine hand use [13]. Content has been linked to the ICF [8] 
and ICF Core Sets for AS, OA, chronic widespread pain, 
low back pain and musculoskeletal conditions for post-acute 
care [11]. Over 80% of people with RMDs considered it 
the right length and helpful for discussing activity abilities 
with an RHP [10, 12]. The English EDAQ is also available 
online. Patients can complete it, store results to their user 
profile and e-mail them to their RHP [14]. Cross-cultural 
adaptation of the EDAQ into other languages would enable 
its use in other countries; and cross-country comparisons of 
patients’ rehabilitation needs and effects of rehabilitation 
on activities. To do this, cross-cultural invariance must be 
demonstrated, i.e. the EDAQ works in a consistent manner 
across language versions [15, 16].
The objectives of this study were to: linguistically vali-
date and cross-culturally adapt the EDAQ for Dutch and 
German speakers with RA; test cross-cultural invariance 
across the Dutch, German and English versions of the EDAQ 
to ensure equivalent scaling; test the psychometric proper-
ties of the Dutch and German EDAQ; and further establish 
content validity in RA by linking the EDAQ to the ICF Core 
Set for RA.
Methods
Participants
Participants were recruited by health service staff iden-
tifying eligibility. Dutch-speakers were recruited from 
one hospital in the Netherlands. German-speakers were 
recruited from three hospitals in Switzerland and from 
Swiss, German and Austrian arthritis patient associations. 
Participants from patient associations volunteered follow-
ing reading study information on associations’ websites 
and completing an eligibility screening form. As the Dutch 
and German language EDAQs were tested for cross-cul-
tural adaptation and invariance with the English EDAQ, 
data from the earlier English study were included [10].
Participants were eligible if they: had a confirmed diag-
nosis of RA; were able to read, write and understand Dutch 
or German (as applicable); and had not (or were not about 
to) altered their disease-modifying medication regimen in 
the last 3 months (which could affect test–retest reliability).
Ethical approval was obtained, and all participants pro-
vided written informed consent.
Phase 1: validation
Linguistic and cross‑cultural validation
Recommended procedures were followed [17, 18]. Valida-
tion occurred in two stages. In stage one, two independent 
forward translations were made for each of the Dutch and 
German versions from the original Swedish EDAQ; these 
were synthesised by expert panels in each country, respec-
tively; independent back translations were made from 
each language into Swedish; followed by synthesis by the 
Swedish language expert panel for each language to check 
for equivalence of meaning. In stage two: additional items 
developed for the English EDAQ were forward/backward 
translated as above into Dutch and German. Harmoniza-
tion of the Dutch, German and English versions by the 
research teams then ensured equivalence.
Field testing of the Dutch and German EDAQs was con-
ducted with people with RA in the Netherlands and Swit-
zerland, respectively, using cognitive debriefing interviews 
[17, 19]. Participants completed the draft Dutch or Ger-
man EDAQ at home and, within 2 weeks, were interviewed 
about comprehensibility, the relevance of the activities for 
people with RA and whether any important daily activi-
ties were missing. The results were discussed between the 
Dutch, German and English research teams. Further word-
ing changes and additional items were agreed to ensure 
equivalence across these three versions.
Rheumatology International 
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Content validity
To further evaluate the content validity of the EDAQ, Part 
2 items were systematically linked to the ICF Core Set for 
RA [20], using content linking rules [21].
Phase 2: Psychometric testing
Participants were mailed a questionnaire booklet which 
collected data to describe the recruited population: age, 
gender, marital, educational and employment status, dis-
ease duration and RA disease-modifying medication, as 
well as the EDAQ and the measures described below. Two 
to three weeks later, participants were mailed the EDAQ to 
complete for a second time at home to evaluate test–retest 
reliability. Two reminders were sent for each mailing, as 
necessary.
Measurement instruments
The EDAQ includes three parts: Part 1 comprises 10 
numerical rating scales (NRS) to assess symptom sever-
ity, mood and life satisfaction, each scored on a 0 (none) 
to 10 (severe) scale. Part 2 comprises 138 activities in 
14 domains. Twelve can be combined into two Compo-
nents: Self-Care (Eating and Drinking; In the Bathroom 
and Personal Care; Getting Dressed/Undressed; Cooking; 
Cleaning the House; Laundry and Clothes Care; Commu-
nication); and Mobility (Bathing and Showering; Mov-
ing Indoors; Moving and Transfers; Moving Outdoors 
and Shopping; Gardening and Household Maintenance). 
The other two domains are Caring; and Leisure, Hobbies 
and Social Activities. Items are scored on a 4-point scale 
assessing ability to perform daily activities (0 = no diffi-
culty, 3 = unable to do). If the person would not normally 
perform that activity (for reasons other than health), there 
is a “not applicable” option. Each item is answered twice 
by rating performance without (Section A) and then with 
(Section B) ergonomic solutions (e.g., alternative meth-
ods, assistive devices, environmental modifications). In 
ICF terminology, section A relates to capacity and B to 
performance [1]. Items are summed to produce total scores 
for Sections A and B within each domain, with any score 
reductions between Sections A and B denoting the impact 
of ergonomic solutions on improving activity ability. If 
there are missing items within a domain, a total domain 
score cannot be calculated. Higher scores indicate greater 
activity limitations. The optional Part 3 includes a list of 
assistive devices and whether owned and used [10]. Part 
3 was not tested as it is not used as an outcome measure.
The comparator health measures to assess concurrent 
validity were:
 (i) The Health Assessment Questionnaire (HAQ): 
assessing ability to perform 20 daily activities rated 
on a 0-3 scale (0 = not at all difficult; 3 = unable to 
do) [22, 23]. These were summed to give a total 
score, as the HAQ20 does not score items worse if an 
assistive device is used [24]. Higher scores indicate 
greater activity limitations.
 (ii) The Physical Function, Bodily Pain and Vitality 
(fatigue) scales of the Medical Outcomes Survey 
36-item Short-Form version 2 (SF36v2), with norm-
based scoring [6, 25]. Lower scores denote worse 
health states.
 (iii) Hand pain: measured using a 11-point NRS of hand/
wrist pain in the past week in during moderate activi-
ties (e.g., cooking a meal, doing housework/light gar-
dening: 0 = no to 10 = severe).
 (iv) RA Quality of Life scale (RAQoL): 30 items about 
QoL answered yes (= 1) or no (= 0), with yes items 
summed to give a total score. Higher scores indicate 
worse QoL [26].
 (v) Perceived health status: using a 5-point NRS asking 
effects of their condition in the last month (1 = very 
good: no symptoms/no limitations in daily activities 
to 5 very poor: very severe symptoms/inability to 
carry out most activities).
 (vi) Perceived change in health status: At Test 2 only, 
a 5-point NRS asking how much arthritis troubled 
them compared to when last completing the question-
naire (1 = much less to 5 = much more).
Sample size
As Rasch analysis was used to assess the invariance of the 
EDAQ Part 2 across language versions, a sample size of at 
least 150 for each language was necessary. This number was 
determined to ensure: a uniform distribution of patients across 
the construct of activity limitation; the precision of the esti-
mate of both persons and items remains similar across the 
construct; and enough cases to test for invariance across 
groups. The sample does not need to be representative, as 
the mathematical model is independent of distribution, but 
it should have a good distribution across the activity domains 
[27]. At least, 79 sets of repeated responses were required to 
demonstrate that a test–retest correlation of 0.7 differed from 
a background correlation (constant) of 0.45, with 90% power 
at the 1% significance level. A test re-test correlation of 0.7 is 
deemed a minimum acceptable level [28].
 Rheumatology International
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Statistical analyses
Cross‑cultural adaptation and invariance
Rasch analysis is an iterative process of fitting data to the 
Rasch Measurement Model [29]. If the data meet the model 
expectations, then ordinal raw scores can be transformed 
into an interval level latent estimate [30]. Those expecta-
tions are associated with several assumptions underlying the 
model, namely stochastic ordering of items, local independ-
ence of items, unidimensionality and group invariance [31]. 
For unidimensionality, a t test of two estimates is made to 
ascertain if more than 5% of such estimates are different, or 
at least at the lower confidence interval for the proportion 
of different tests [32]. Rasch analysis of the English EDAQ 
Part 2 has already determined that total domain scores and 
component scores can be considered as unidimensional and 
total raw scores used [10]. Total domain and component 
scores can be converted to a Rasch metric when required for 
parametric analyses [33].
In cross-cultural adaptation, group invariance is crucial, 
as this determines if the adaptation has provided equivalent 
scaling, in this case across languages. Invariance is tested 
through Differential Item Functioning (DIF) [27]. As both 
the Dutch and German versions of the scale were made from 
the English version, invariance was tested from the English 
version for each, and across all three languages combined. 
The 12 domains of the two components of Self-Care and 
Mobility were used as testlets (as already determined in the 
earlier English Rasch analysis [10] and were the summed 
score of the items within each domain [34]. If local depend-
ency remained across the domains these were further aggre-
gated, as required. The analysis fits data to the Rasch model 
for each component (i.e. Self-Care and Mobility). at their 
respective domain levels. The RUMM2030 software was 
used [35].
Psychometric testing
The Statistical Package for the Social Sciences (SPSS) v25 
was used for analyses [36], apart from linear weighted kap-
pas, calculated using MedCalc [37]. As all measures consist 
of ordinal data, non-parametric statistical tests were used to 
assess the psychometrics, apart for intra-class correlation 
coefficients [ICC (2,1)] and sensitivity to change statistics, 
which were calculated using Rasch transformed data as 
interval data is required for these calculations [33]. Ordinal 
data are summarized as medians and inter-quartile ranges. 
Normality of Rasch transformed data was tested using the 
Kolmogorov–Smirnov test and data summarized using 
means and standard deviations.
Test–retest reliability EDAQ part 1 NRS were assessed 
using linear weighted kappas, as were individual Part 2 
domain items. Agreement of ≥ 0.61 is good [38]. Part 2 
domain total scores were assessed using: (a) Spearman’s 
correlations (with a correlation of ≥ 0.6 being strong [39]); 
and (b) ICC (2,1): two-way random consistency, average 
measures model, with ICC ≥ 0.75 considered excellent [40].
Internal consistency was assessed using Cronbach’s 
alpha, with results of ≥ 0.80 being good to excellent [39].
Concurrent validity of the Part 1 NRS and Part 2 domain 
total scores was assessed using Spearman’s correlations with 
measures of related constructs. For Part 1, this was the SF-
36v2 sub-scales, except for Satisfaction with Life correlated 
with the RAQOL. For Part 2, this was the HAQ20, SF-36v2 
sub-scales, RAQoL, Pain, Fatigue and Hand Pain NRS and 
Perceived Health Status.
Discriminant validity was assessed using Kruskal–Wallis 
tests to evaluate differences in scores between participants 
with different perceived health status groups.
Sensitivity to change was assessed by calculating Stand-
ard Error of Measurement (SEM) and the Minimal Detecta-
ble  Change95  (MDC95). The formula used was: SEM = s√(1 
− r), where s = the mean and standard deviation (SD) of Test 
1 and Test 2 (retest), r = the reliability coefficient for the test, 
i.e. Pearson’s correlation co-efficient between Test and Test 
2 values. Thereafter the  MDC95 was calculated using the 
formula:  MDC95 = SEM × √2 × 1.96 [41, 42].
Floor and ceiling effects were considered present if > 15% 
of participants achieved either the lowest or highest scores 
in the 14 EDAQ Part 2 domains [43].
Results
Phase 1: validation
The only difficulties encountered during translation were 
identifying names for some assistive devices in part 3. This 
was overcome with photographs and local therapists pro-
viding correct names. Cognitive debriefing interviews were 
undertaken with six Dutch- and five German-speaking par-
ticipants. Average time to complete all three parts of the 
EDAQ was 30 (SD 8) minutes. Activities in the EDAQ 
Part 2 were considered culturally relevant by both Dutch 
and German participants. Some additional activities were 
added to existing items: use of smartphones; laptop/tablet 
(e.g. iPad) to the Communication domain; bicycling to the 
Leisure, Hobbies and Social Activities domain. Ten consid-
ered it easy/partially easy to complete, with five highlight-
ing the importance of carefully reading instructions. Eight 
commented that Part 2 (activities) was most relevant and 
three that Part 3 (assistive devices) least relevant because 
those participants had few or no assistive devices. Seven 
considered the EDAQ included the right range and number 
of activities. However, four thought there were too many. 
Rheumatology International 
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All 11 participants considered the EDAQ would capture the 
difficulties they face daily and enable discussions with reha-
bilitation health professionals.
Linking to the ICF Core Set for RA
The Part 2 EDAQ had good content validity, with 28/33 
activities from the Communication, Mobility, Self-Care 
and Domestic Life items of the RA Core Set included. The 
five Core Set activities not included were not specific daily 
activities: carrying out daily routine (d230); Interpersonal 
family (d760) and intimate (d770) relationships; and Major 
Life areas: remunerative (d850) and other work/employment 
(d859). (see Supplementary Table S1).
Phase 2: psychometric testing
Participants
The sample consisted of 252 Dutch-speaking people from 
the Netherlands and 163 German-speaking people (87 
from Switzerland, 70 from Germany and 6 from Austria). 
Their language group-specific demographic characteris-
tics and disease duration are shown in Table 1 and health 
status in Table 2. Demographic and health data for the 
Table 1  Rheumatoid Arthritis participants’ demographic characteristics completing the Evaluation of Daily Activity Questionnaire Dutch, Ger-
man and English versions
DMARDS disease modifying anti-rheumatic drugs
RA Dutch (n = 252) RA German (n = 163) RA English (n = 369)
Age: years: mean (SD) 65.16 (13.45) 52.84 (14.94) 60.38 (11.19)
Gender M:F; n (%) 93:155 (38:62%) 18:145 (11:89%) 97:286 (25:75%)
Condition duration in years: mean (SD) 11.75 (9.93) 15.73 (12.12). 13.20 (10.70)
Marital status: n (%)
- Married/living with a partner 179 (71%) 102 (62.58%) 276 (72%)
Living status: n (%)
- With family/significant other 177 (70%) 107 (66%) 292 (76%)
- Children living at home n (%): 20 (8%) 21 (13%) 92 (24%)
Employment status: n (%)
- Paid employment 68 (27%) 85 (52%) 118 (31%)
Education level: n (%)
- Secondary education only 189 (75%) 94 (58%) 174 (45%)
Current medication: n (%)
- DMARDs 163 (65%) 56 (34%) 193 (50%)
- Biologic drugs 43 (17%) 80 (49%) 161 (42%)
Perceived Health: n (%) (n = 239) (n = 162) (n = 378)
- Very good/good (1-2) 144 (60%) 82 (51%) 135 (35%)
- Fair (3) 79 (33%) 60 (37%) 146 (38%)
- Poor/Very Poor (4-5) 16 (7%) 20 (12%) 97 (25%)
Numbers answering Test 2 155 107 –
Table 2  Health status measures 
in the Evaluation of Daily 
Activity Questionnaire Dutch, 
German and English versions in 
Rheumatoid Arthritis: median 
(inter-quartile range)
HAQ Health Assessment Questionnaire, SF36v2 Short Form 36v2, RAQoL Rheumatoid Arthritis Quality 
of Life scale, Higher scores better in SF36v2, Lower scores better in HAQ20 and RAQOL
Measure (score range) RA Dutch (n = 252) RA German (n = 163) RA English (n = 369)
HAQ20 (0–60) 4 (1–15) 7 (2–14) 13 (4–24)
SF36v2 physical function (0–100) 44.51 (32.66–51.80) 44.15 (36.01–51.80) 34.57 (25.01–44.15)
SF36v2 bodily pain (0–100) 46.68 (38.61–55.55) 42.24 (38.21–50.71) 38.21 (34.18–46.68)
SF36v2 vitality (0–100) 52.60 (46.66–58.54) 49.63 (40.72–52.60) 40.72 (31.80–49.63)
SF36v2 mental health (0–100) 53.48 (43.02–58.72) 50.87 (43.02–56.10) 50.87 (40.40–56.10)
RAQoL (0–30) 5.50 (2–12) 8 (4–15) 13 (5–20)
Hand pain (0–100) 3 (1–5) 3 (1–5) 5 (2–7)
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English-speaking participants (n = 383), included in the 
Rasch analysis, is also shown. The Dutch sample, compared 
to the German and English-speaking samples, were older 
with: more men; shorter disease duration; less educational 
experience; fewer on biologics; and better health status.
Rasch analysis
Fit of the data to the Rasch model for each component and 
language is shown in Table 3. In most cases, adequate fit to 
the model was observed, along with unidimensionality (ideal 
values are shown at the bottom of the table). Overall, there 
was only sporadic DIF at the domain level, with no consist-
ent pattern. Where DIF did occur, the magnitude of differ-
ence in the mean locations of groups defined by their level of 
disability was small. It was always present in only one of the 
groups, always at the margins, that is either, ‘no/little’ self- 
care disability or ‘highest’ self- care disability. When the 
domains were further grouped into larger super items, the 
DIF was no longer present, suggesting that at the test level, 
DIF would cancel out. There was little DIF observed by 
language indicating that the hierarchical ordering of domains 
remained the same across the language pairwise analyses. 
Only for the combined analysis of the domains within the 
mobility component was it necessary to merge the domains 
into super items to obtain fit (a conditional test of fit is pro-
vided at this level). Rasch transformation tables converting 
component raw scores to interval scales are shown in Sup-
plementary Tables S3 and S4.
Test–retest reliability
Part 1: the 10 NRS had moderate to good reliability 
(Table 4).
Part 2: correlations between test 1 and 2 domain scores 
were good or very good (rs = 0.75 to 0.93), apart from 
the Caring domain which had only moderate correlations 
(Table 5). The domains’ intra-class correlations were excel-
lent [ICC (2,1) = 0.90 to 0.97], apart from Gardening and 
Household Maintenance (Dutch) which was lower at 0.77 
(Table 5). Linear weighted kappa scores for individual items 
in each domain were mainly moderate to good (0.20–0.75 
Dutch; 0.41–0.82 German version) (Supplementary Table 2).
Internal consistency
Cronbach’s alpha values for the 14 domains were all excel-
lent (≥ 0.85) apart from Communication (0.79) in the Dutch 
version (Table 5). All domains in both languages, therefore, 
had values consistent with group use (i.e. ≥ 0.7), and most 
with individual use (i.e. ≥ 0.85) [28]. Each domain can be 
used as a stand-alone measure, as well as collectively within 
the two components of Self-Care and Mobility.
Concurrent validity
In EDAQ Part 1, there were moderate to strong correlations 
between NRS and SF36v2 Mental Health, Vitality and Bod-
ily Pain scales and RAQOL, as relevant (rs =  − 0.42 to 
− 0.73) Table 4).
Table 3  Fit of Evaluation of Daily Activity Questionnaire components to the Rasch model: Dutch, German and English versions
DF degrees of freedom, CI = confidence interval, ~ conditional test of fit
*Bonferroni adjusted = 0.008 within each component
Chi-Square DF P Reliability Unidimensionality % t 
test significant
Lower CI of t test N
Self-care
Dutch 37.2 28 0.11 0.81 6.8 4.0 220
German 11.8 14 0.62 0.89 6.7 3.2 150
English 35.9 42 0.74 0.91 4.6 2.2 369
Dutch and English 70.6 63 0.24 0.88 4.7 2.9 589
German & English 59.4 63 0.61 0.90 3.9 2.0 519
Combined 67.8 63 0.32 0.88 4.8 3.1 739
Mobility
Dutch 44.6 25 0.01 0.80 3.2 0.3 220
German 16.0 10 0.10 0.88 6.5 3.0 150
English 16.6 25 0.89 0.88 4.0 1.6 369
Dutch and English 18.7 18 0.41 0.86 2.3 − 0.6 589
German and English 40.8 35 0.23 0.88 5.5 3.5 519
Combined 78.8 83 0.60 ~ 0.87 3.3 1.1 739
Ideal values > 0.05* > 0.85 <5 .0 < 5.0
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In EDAQ Part 2, most domains correlated strongly with 
physical function measures: HAQ20 (rs = 0.65 to 0.87), 
apart from Gardening and Household Maintenance (Dutch) 
and Caring (Dutch and German) which were moderate; and 
SF36v2 Physical Function (rs = − 0.61 to − 0.87), apart from 
Bathroom and Personal Care, Communication, Gardening 
and Household Maintenance which were moderate and Car-
ing which was weak in the Dutch version and moderate in 
the German version.
The Part 2 domains correlated moderately/strongly with 
pain symptoms: SF36v2 Bodily Pain (rs = − 0.44 to − 0.67); 
Hand Pain (rs = 0.43–0.64); and Pain (rs = 0.46–0.66) apart 
from Gardening and Household Maintenance (Dutch) 
which was weak. Generally, EDAQ domains correlated 
only moderately with fatigue symptoms in the Dutch ver-
sion (rs = − 0.35 to − 0.75) and weakly to moderately in 
the German version (rs = 0.26–0.42). The RAQoL correlated 
moderately to strongly with EDAQ domains (rs = 0.50–0.83). 
Table 4  Evaluation of Daily 
Activity Questionnaire Part 
1: test–retest reliability and 
concurrent validity in the Dutch 
(n = 252) and German (n = 163) 
versions
For all EDAQ Part 1 scales and RAQOL, higher scores are worse; SF36v2 higher scores are better
rs Spearman’s correlation coefficient
***p = < 0.001; **p < 0.01; *p < 0.05
a Short Form F36v2 Physical Function scale
b Short Form 36v2 Pain scale
c Short Form 36 v2 Vitality scale
d SF36v2 Mental Health scale
e RAQOL. Not all scales had directly applicable comparator measures
Part 1 EDAQ numeric rating 
scale: (0–10)
Test 1
Median (IQR)
Test 2
Median (IQR)
Test–retest reliability 
linear weighted kappa
Comparator 
measures 
(rs)
1: Disease activity
Dutch 3.5 (2–6) 4 (2–6) 0.42 − 0.45a***
German 4 (2–6) 4 (2–6) 0.43 − 0.43a***
2: Mood
Dutch 1 (0–4) 2 (0–4) 0.40 − 0.64d***
German 3 (2–6) 3 (2–6) 0.46 − 0.57d***
3: Pain when resting
Dutch 2 (1–4) 2 (1–4) 0.50 − 0.68b***
German 2 (1–5) 3 (1–5) 0.48 − 0.63b***
4: Pain when moving
Dutch 3 (1–6) 3 (1.75–5) 0.60 − 0.73b***
German 4 (2–6) 4 (2–6) 0.52 − 0.73b***
5: Stiffness
Dutch 3 (1–6) 3 (2–5) 0.58 − 0.55a***
German 3 (1–5) 3 (1–6) 0.60 − 0.52a***
6: Joint movement limitations
Dutch 3 (1–6) 3 (1–6) 0.64 − 0.64a***
German 4 (2–6) 3 (2–6) 0.60 − 0.69a***
7: Fatigue
Dutch 4 (2–7) 4 (1.75–6) 0.60 − 0.72c***
German 5 (3–7) 5 (2–7) 0.59 − 0.72c***
8: Worry
Dutch 3 (1–5) 2 (1–4) 0.59 − 0.52d***
German 2 (1–5) 2 (1–5) 0.49 − 0.67d***
9: Sleep
Dutch 2 (0–5) 2 (1–5) 0.62 − 0.48b***
German 3 (1–6) 3 (1–6) 0.69 − 0.42b***
10: Satisfaction with life
Dutch 1 (0–3) 1 (0–3) 0.53 0.55e***
German 3 (1–5) 3 (1–6) 0.51 0.57e***
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Perceived Health State was moderately to strongly correlated 
(rs = 0.47–0.65). Apart from being moderately correlated 
with physical function measures, the Caring domain was 
weakly correlated with other measures (Table 6).
Discriminant validity
There were significant differences in most Part 2 domain 
scores (p < 0.01), except for the Dutch Caring domain 
(p = 0.27), as many participants reported not performing 
Caring activities (Supplementary Table 7).
Sensitivity to change
Part 2  MDC95 domain scores ranged from 1.25 to 3.68 apart 
from Gardening and Household Maintenance which was 
higher (7.77) for the Dutch EDAQ (Table 5).
Floor and ceiling effects
In the Dutch EDAQ all Part 2 domains, except Move Out-
doors, had floor effects. For the German EDAQ all domains, 
except Eating, Move Indoors, Cleaning, Move Outdoors had 
floor effects. There were no celling effects in either version.
Discussion
This study has produced linguistically validated and cul-
turally relevant Dutch and German versions of the EDAQ 
which are now available for use. No changes were needed 
to be culturally relevant, with only a few additions neces-
sary to further update content across language versions. 
In field testing, both versions were acceptable to partici-
pants, despite their length, and considered as helpful in 
improving communication about their activity limitations 
with health professionals. Both versions demonstrated good 
psychometric properties in people with RA from the Nether-
lands and Switzerland, Germany and Austria, respectively. 
They meet most of the recommendations for PROMs of the 
United States Food and Drug Administration [44] and the 
Consensus-based Standards for the selection of health Meas-
urement Instruments (COSMIN) checklist [45, 46], although 
responsiveness still needs evaluating in a clinical trial or set-
ting. Consequently, the EDAQ can also be used in research 
and audit, as well as clinical practice.
In terms of validity, the EDAQ Part 2 has good con-
tent validity covering most of the items in the Activities 
and Participation component of the ICF Core Set for RA. 
Good construct validity was demonstrated by satisfying 
Rasch model expectations. As at domain level no DIF 
was observed, raw scores for items in each component 
can be summed to create both total domain and component 
scores. Data can also be pooled across countries/languages 
and comparative studies of EDAQ data conducted.
Concurrent validity of the Dutch and German versions 
of the EDAQ reflected previous studies in the English 
EDAQ with people with RA and other RMDs, with strong 
correlations with physical function, moderate to strong 
with pain and moderate with fatigue [10, 12]. In all three 
language versions, the Caring domain had only weak cor-
relations with other measures, predominantly because few 
had caring responsibilities. Further research is needed to 
test this domain in samples with a larger number of parents 
with young children to test validity for those with caring 
responsibilities. Internal consistency and test–retest reli-
ability were similar to the English EDAQ results, and indi-
cate the EDAQ can be used for both group and individual 
measurement in RA. As each domain is valid and reliable, 
health professionals can choose which domains to use in 
clinical practice. For example, the client may complete all 
the EDAQ initially. If their rehabilitation focuses only on 
selected domains, then at follow-up the client need only 
complete those domains.
A strength of this study is that it included a large sample 
of people with RA, recruited from both out-patient clin-
ics and patient associations. Recruitment was from three 
German-speaking countries. Two German versions have 
been developed: one for Switzerland, and one for Germany 
and Austria, as there are minor differences in written Ger-
man. Although the English version has been tested in eight 
RMDs, the Dutch and German EDAQs have only been tested 
in RA. Further research is needed to establish whether the 
Dutch and German EDAQs are reliable and valid in other 
RMDs. This would allow the EDAQ to be used across these 
language versions/countries in a wide variety of RMDs com-
monly treated in rheumatology departments and in other 
settings.
The limitations of this study are that, in Phase 2, the 
acceptability and utility of the EDAQ were not investigated, 
as in the English studies, although Phase 1 participants 
endorsed these. Additionally, floor effects were observed 
across most domains (particularly the Dutch sample). This 
is likely because the Dutch sample included a higher propor-
tion of men, compared to the German and English samples. 
Men with RA tend to have fewer daily activity difficulties 
than women, predominantly because of their stronger grip 
force [47]. Additionally, in this Dutch sample more reported 
being in good health.
In conclusion, the Dutch and German EDAQs are valid, 
reliable measures of activity limitations which can be used 
with people with RA. Either the whole EDAQ, the Self-
Care/Domestic Life or Mobility components or the indi-
vidual domains can be used in clinical practice to identify 
client’s daily activity difficulties, facilitate discussion to find 
solutions, and evaluate the outcome. Equivalence between 
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Table 6  Evaluation of Daily Activity Questionnaire Part 2: concurrent validity with comparator measures (Dutch n = 252; German n = 163)
EDAQ 
domain sec-
tion A (score 
range)
HAQ20 (rs) SF36v2: PF 
(rs)
SF36v2: 
bodily pain 
(rs)
SF36v2: 
vitality (rs)
Quality of 
life: RAQOL 
(rs)
Pain NRS 
(rs)
Fatigue NRS 
(rs)
Hand pain 
NRS (rs)
Perceived 
health (rs)
1: Eating 
and drink-
ing (0–33)
Dutch 0.77*** − 0.63*** − 0.58*** − 0.50*** 0.69** 0.59*** 0.60*** 0.61*** 0.49***
German 0.77*** − 0.70*** − 0.58*** − 0.30*** 0.55*** 0.48*** 0.26*** 0.50*** 0.52***
2: In the 
bathroom 
and per-
sonal care 
(0–36)
Dutch 0.67*** − 0.57*** − 0.47*** − 0.40*** 0.65*** 0.52*** 0.56*** 0.50*** 0.55***
German 0.81*** − 0.70*** − 0.53*** − 0.34*** 0.57*** 0.52*** 0.35*** 0.44*** 0.50***
3: Dressing 
(0–33)
Dutch 0.75*** − 0.64*** − 0.59*** − 0.48*** 0.65*** 0.56*** 0.57*** 0.58*** 0.53***
German 0.79*** − 0.73*** − 0.56*** − 0.27*** 0.55*** 0.57*** 0.28*** 0.43*** 0.53***
4: Bath-
ing and 
showering 
(0–33)
Dutch 0.86*** − 0.79*** − 0.61*** − 0.54*** 0.76*** 0.61*** 0.65*** 0.62*** 0.55***
German 0.83*** − 0.79*** − 0.53*** − 0.33*** 0.58*** 0.56*** 0.38*** 0.46*** 0.55***
5: Cooking 
(0–42)
Dutch 0.82*** − 0.73*** − 0.61*** − 0.55*** 0.74*** 0.58*** 0.63*** 0.61*** 0.54***
German 0.87*** − 0.81*** − 0.60*** − 0.40*** 0.68*** 0.58*** 0.38*** 0.52*** 0.59***
6: Moving 
indoors 
(0–36)
Dutch 0.85*** − 0.83*** − 0.66*** − 0.60*** 0.83*** 0.65*** 0.75*** 0.64*** 0.54***
German 0.83*** − 0.84*** − 0.63*** − 0.36*** 0.65*** 0.60*** 0.37*** 0.51*** 0.64***
7: Cleaning 
the house 
(0–27)
Dutch 0.79*** − 0.76*** − 0.61*** − 0.52*** 0.74*** 0.52*** 0.59*** 0.57*** 0.52***
German 0.87*** − 0.83*** − 0.59*** − 0.30*** 0.63*** 0.54*** 0.32*** 0.52*** 0.56***
8: Laundry 
and clothes 
care (0–27)
Dutch 0.75*** − 0.68*** − 0.56*** − 0.51*** 0.65*** 0.46*** 0.55*** 0.52*** 0.47***
German 0.86*** − 0.76*** − 0.53*** − 0.31*** 0.57*** 0.48*** 0.32*** 0.49*** 0.52***
9: Moving 
and trans-
fers (0–18)
Dutch 0.78*** − 0.66*** − 0.60*** − 0.62*** 0.77*** 0.61*** 0.68*** 0.60*** 0.56***
German 0.77*** − 0.76*** − 0.60*** − 0.42*** 0.68*** 0.64*** 0.42*** 0.50*** 0.64***
10: Com-
munication 
(0–18)
Dutch 0.65*** − 0.55*** − 0.52*** − 0.45*** 0.63*** 0.54*** 0.51*** 0.59*** 0.48***
German 0.73*** − 0.61*** − 0.49*** − 0.38*** 0.55*** 0.46*** 0.33*** 0.44*** 0.52***
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these and the English language version means that data from 
these different versions can be combined.
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Table 6  (continued)
EDAQ 
domain sec-
tion A (score 
range)
HAQ20 (rs) SF36v2: PF 
(rs)
SF36v2: 
bodily pain 
(rs)
SF36v2: 
vitality (rs)
Quality of 
life: RAQOL 
(rs)
Pain NRS 
(rs)
Fatigue NRS 
(rs)
Hand pain 
NRS (rs)
Perceived 
health (rs)
11: Moving 
outdoors 
and shop-
ping (0–39)
Dutch 0.88*** − 0.87*** − 0.67*** − 0.59*** 0.83*** 0.63*** 0.67*** 0.60*** 0.59***
German 0.87*** − 0.87*** − 0.65*** − 0.41*** 0.71*** 0.66*** 0.42*** 0.52*** 0.65***
12: Garden-
ing and 
household 
mainte-
nance 
(0–21)
Dutch 0.51*** − 0.54*** − 0.44*** − 0.35*** 0.50*** 0.39*** 0.45*** 0.46*** 0.31***
German 0.76*** − 0.79*** − 0.57*** − 0.33*** 0.63*** 0.53*** 0.33*** 0.47*** 0.57***
13: Caring 
(0–27)
Dutch 0.31** − 0.22** − 0.22** − 0.16** 0.28*** 0.18** 0.17** 0.24*** 0.16*
German 0.42*** − 0.40*** − 0.31*** − 0.10 0.25** 0.37*** 0.14 0.26** 0.27***
14: Leisure, 
hobbies 
and social 
activities 
(0–27)
Dutch 0.76*** − 0.64*** − 0.65*** − 0.55*** 0.71*** 0.57*** 0.60*** 0.60*** 0.57***
German 0.76*** − 0.77*** − 0.58*** − 0.40*** 0.68*** 0.55*** 0.41*** 0.47*** 0.60***
***p = < 0.001; **p < 0.01; *p < 0.05
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de-identified datasets may be granted following review. The EDAQ, 
EDAQ-D, EDAQ-NL and EDAQ Manualv3 are available for free 
download from the University of Salford Institutional Repository: 
http://usir.salfo rd.ac.uk/id/eprin t/30752 ; and/46269/46275/and/46276).
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